000 | 01553 a2200445 4500 | ||
---|---|---|---|
005 | 20250513112034.0 | ||
264 | 0 | _c19970305 | |
008 | 199703s 0 0 eng d | ||
022 | _a0022-1767 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPender, S L | |
245 | 0 | 0 |
_aA major role for matrix metalloproteinases in T cell injury in the gut. _h[electronic resource] |
260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cFeb 1997 |
||
300 |
_a1582-90 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aCell-Free System _xenzymology |
650 | 0 | 4 | _aEnzyme Activation |
650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aEnzyme Precursors _xanalysis |
650 | 0 | 4 | _aFetus |
650 | 0 | 4 | _aGene Expression Regulation, Developmental |
650 | 0 | 4 |
_aGlycoproteins _xanalysis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntestinal Mucosa _xenzymology |
650 | 0 | 4 | _aIntestine, Small |
650 | 0 | 4 | _aMatrix Metalloproteinase Inhibitors |
650 | 0 | 4 |
_aMetalloendopeptidases _xantagonists & inhibitors |
650 | 0 | 4 | _aOrgan Culture Techniques |
650 | 0 | 4 |
_aPeptides _xtherapeutic use |
650 | 0 | 4 |
_aRecombinant Proteins _xtoxicity |
650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
650 | 0 | 4 | _aTissue Inhibitor of Metalloproteinases |
700 | 1 | _aTickle, S P | |
700 | 1 | _aDocherty, A J | |
700 | 1 | _aHowie, D | |
700 | 1 | _aWathen, N C | |
700 | 1 | _aMacDonald, T T | |
773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 158 _gno. 4 _gp. 1582-90 |
|
999 |
_c9018621 _d9018621 |